Catarina Remédios

Catarina Remédios

Auto-generated profile, based on publicly available information

Catarina Remédios

1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2014 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
Antonella SistiguAntonella Sistigu
Antonella Sistigu
TYTakahiro Yamazaki
Takahiro Yamazaki
EVErika Vacchelli
Erika Vacchelli
KCKariman Chaba
Kariman Chaba
DEDavid P Enot
David P Enot
LZLaurence Zitvogel
Laurence Zitvogel

17 June 2012 in Journal of Botany
Verified
Journal Article
Open access
PDF file
CRC. Remédios
C. Remédios
FRF. Rosário
F. Rosário
Verónica BastosVerónica Bastos
Verónica Bastos
Nanoparticles (NPs) are characterized by their small size (less than 100 nm) and large surface area, which confer specific physicochemical properties as strength, electrical, and optical features. NPs can be derived from natural or anthropic sources, such as engineered or unwanted/incidental NPs. The composition, dimension, and morphology of engineered NPs enable their use in a variety of areas, such as electronic, biomedical, pharmaceutical, cosmetic, energy, environmental, catalysis, and materials science. As nanotechnology is an innovative and scientific growth area with an exponential production, more information is needed concerning the impacts of these nanomaterials (NMs) in the environment and, particularly, in animals/humans health and in plants performance. So, research on NPs as emerging contaminants is therefore a new field in environmental health. This minireview describes, briefly, the NPs characterization and their occurrence in the environment stating air, water, and soil. Finally, particular emphasis is given to the interaction of NPs with plants at different levels: morphology, physiology, and genotoxicity. By analyzing this compiled information, it is evident that research on NPs phytotoxicity is in the beginning, and more comprehensive studies are needed not only on NPs cytotoxicity and genotoxicity but also on the best and the most reliable methods of assessing NPs toxicity.

1 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JOJosé Miguel P. Ferreira de Oliveira
José Miguel P. Ferreira de Oliveira
MCMaria Eugenia MARQUES DA COSTA
Maria Eugenia MARQUES DA COSTA
TPTiago Pedrosa
Tiago Pedrosa
Pedro Viana PintoPedro Viana Pinto
Pedro Viana Pinto
CRCatarina Remédios
Catarina Remédios
Conceição SantosConceição Santos
Conceição Santos
Sulforaphane (SFN) is a naturally-occurring isothiocyanate best known for its role as an indirect antioxidant. Notwithstanding, in different cancer cell lines, SFN may promote the accumulation of reactive oxygen species (ROS) and cause cell death e.g. by apoptosis. Osteosarcoma often becomes chemoresistant, and new molecular targets to prevent drug resistance are needed. Here, we aimed to determine the effect of SFN on ROS levels and to identify key biomarkers leading to ROS unbalance and apoptosis in the p53-null MG-63 osteosarcoma cell line. MG-63 cells were exposed to SFN for up to 48 h. At 10 μM concentration or higher, SFN decreased cell viability, increased the%early apoptotic cells and increased caspase 3 activity. At these higher doses, SFN increased ROS levels, which correlated with apoptotic endpoints and cell viability decline. In exposed cells, gene expression analysis revealed only partial induction of phase-2 detoxification genes. More importantly, SFN inhibited ROS-scavenging enzymes and impaired glutathione recycling, as evidenced by inhibition of glutathione reductase (GR) activity and combined inhibition of glutathione peroxidase (GPx) gene expression and enzyme activity. In conclusion, SFN induced oxidative stress and apoptosis via a p53-independent mechanism. GPx expression and activity were found associated with ROS accumulation in MG-63 cells and are potential biomarkers for the efficacy of ROS-inducing agents e.g. as co-adjuvant drugs in osteosarcoma.

23 December 2013 in Nutrition and Cancer
Verified
Journal Article
Closed access
JOJosé Miguel P. Ferreira de Oliveira
José Miguel P. Ferreira de Oliveira
CRCatarina Remédios
Catarina Remédios
HOHelena Oliveira
Helena Oliveira
Pedro Viana PintoPedro Viana Pinto
Pedro Viana Pinto
FPFrancisco Pinho
Francisco Pinho
Conceição SantosConceição Santos
Conceição Santos
Osteosarcoma is a recalcitrant bone malignancy with poor responsiveness to treatments; therefore, new chemotherapeutic compounds are needed. Sulforaphane (SFN) has been considered a promising chemotherapeutic compound for several types of tumors by inducing apoptosis and cytostasis, but its effects (e.g., genotoxicity) in osteosarcoma cells remains exploratory. In this work, the MG-63 osteosarcoma cell line was exposed to SFN up to 20 μM for 24 and 48 h. SFN induced G2/M phase arrest and decreased nuclear division index, associated with disruption of cytoskeletal organization. Noteworthy, SFN induced a transcriptome response supportive of G2/M phase arrest, namely a decrease in Chk1- and Cdc25C-encoding transcripts, and an increase in Cdk1-encoding transcripts. After 48-h exposure, SFN at a dietary concentration (5 μM) contributed to genomic instability in the MG-63 cells as confirmed by increased number of DNA breaks, clastogenicity, and nuclear and mitotic abnormalities. The increased formation of nucleoplasmic bridges, micronuclei, and apoptotic cells positively correlated with loss of viability. These results suggest that genotoxic damage is an important step for SFN-induced cytotoxicity in MG-63 cells. In conclusion, SFN shows potential to induce genotoxic damage at low concentrations and such potential deserves further investigation in other tumor cell types.

1 March 2013 in Journal of Plant Physiology
Verified
Journal Article
Closed access
ERE. Rodriguez
E. Rodriguez
RAR. Azevedo
R. Azevedo
CRC. Remédios
C. Remédios
TAT. Almeida
T. Almeida
PFP. Fernandes
P. Fernandes
Conceição SantosConceição Santos
Conceição Santos